Ravi Anand

Summary

Country: Switzerland

Publications

  1. ncbi request reprint Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers
    Ravi Anand
    Anand Pharma Consulting, Oberwil, Switzerland
    Clin Pharmacokinet 46:351-8. 2007
  2. ncbi request reprint Electrocardiographic effects of rivastigmine
    Joel Morganroth
    eResearch Technology, Philadelphia, PA 19103, USA
    J Clin Pharmacol 42:558-68. 2002

Collaborators

  • Joel Morganroth
  • Stephen Graham
  • Richard Hartman

Detail Information

Publications2

  1. ncbi request reprint Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers
    Ravi Anand
    Anand Pharma Consulting, Oberwil, Switzerland
    Clin Pharmacokinet 46:351-8. 2007
    ..This article reports on the results of the first administration of FGL(L) in humans...
  2. ncbi request reprint Electrocardiographic effects of rivastigmine
    Joel Morganroth
    eResearch Technology, Philadelphia, PA 19103, USA
    J Clin Pharmacol 42:558-68. 2002
    ..Percentage change from baseline for PR, QRS, and QTc intervals was also no different. In conclusion, rivastigmine appears not to produce adverse effects on cardiac function assessed by ECG...